Additional Issuance of Securities. So long as the Buyer beneficially owns any Warrants, the Company will not, without the prior written consent of the Buyer, issue any other securities that would cause a breach or default under the Note or the Warrants.
Appears in 1 contract
Sources: Securities Purchase Agreement
Additional Issuance of Securities. So long as the Buyer any Purchaser beneficially owns any WarrantsSecurities, the Company will not, without the prior written consent of the BuyerRequired Holders, issue any other securities that would cause a breach or default under the Note or the Warrants.
Appears in 1 contract
Sources: Securities Purchase Agreement (Broadcast International Inc)
Additional Issuance of Securities. So long as the any Buyer beneficially owns any WarrantsSecurities, the Company will shall not, without the prior written consent of the BuyerRequired Holders, issue any Series D Preferred Shares (other than to the Buyers as contemplated hereby) and the Company shall not issue any other securities that would cause a breach or default under the Note or the WarrantsCertificate of Designations.
Appears in 1 contract
Sources: Securities Purchase Agreement (Cero Therapeutics Holdings, Inc.)
Additional Issuance of Securities. So long as the Buyer beneficially owns any WarrantsSecurities, the Company will not, without the prior written consent of the Buyer (which may be granted or withheld in the Buyer’s sole discretion), issue any other securities that would cause a breach or default under any of the Note or the Series M Warrants.
Appears in 1 contract
Sources: Securities Purchase Agreement (Cardiff Oncology, Inc.)
Additional Issuance of Securities. So long as the Buyer beneficially owns any WarrantsSecurities, the Company will not, without the prior written consent of the Buyer (which may be granted or withheld in the Buyer’s sole discretion), issue any other securities that would cause a breach or default under any of the Note Series B Stock or the Warrants.
Appears in 1 contract
Sources: Securities Purchase Agreement (Cyclacel Pharmaceuticals, Inc.)
Additional Issuance of Securities. So long as the any Buyer beneficially owns any WarrantsSecurities, the Company will not, without the prior written consent of the BuyerRequired Holders, issue any Preferred Shares (other than to the Buyers as contemplated hereby) and the Company shall not issue any other securities that would cause a breach or default under the Note or the Warrants.Certificate of
Appears in 1 contract